-
Continuing with the series providing a global perspective on integrating mental health, Sylvia Kaaya and colleagues discuss the importance of integrating mental health interventions into HIV prevention and treatment platforms.
22 May 2013 | PLoS Blogs (blog)
-
Community panel on recent gay club deaths in London at Royal Vauxhall Tavern at 7pm on Thursday 9 May
05 May 2013 | Time Out
-
For those taking antiretroviral medications for HIV/AIDS, there is one drug in the mix that can put a particular kick in the cocktail: the drug efavirenz, marketed under the commercial names Sustiva and Stocrin, appears to have an "LSD-like interaction" with the receptors in the brain that govern the activity of serotonin, says a study presented in Boston today.
23 April 2013 | Los Angeles Times
-
My generation, which continues to stare down HIV, is facing a new plague -- the one that likely killed Spencer Cox. As yet unnamed, it manifests in aimlessness, depression, broken relationships, substance abuse, unsafe sex and suicide.
04 February 2013 | Huffington Post (blog)
-
This death hit us hard. We have grappled to make sense of it. Why did he stop his meds? What role did his struggle with crystal meth play? Was this a failure of community? Are there lessons we can learn? These aren't just nosy questions by idle bystanders.
25 January 2013 | Huffington Post
-
David Stuart of gay men's drug project Antidote discusses increases in the use of methamphetamine and mephedrone in London's gay scene and an increased tendency to inject them.
24 January 2013 | Pink News
-
When Spencer Cox died on December 18, 2012, in New York City, the official cause of death was AIDS-related complications, which is understandable if post-traumatic stress, despair and drug addiction are complications related to AIDS. Spencer believed that this connection exists.
03 January 2013 | My Fabulous Disease
-
European Liver Patients Association (ELPA) invited leading psychologists, psychiatrists and hepatologists to an expert conference in 2011. Martin Schaefer MD and his colleagues reviewed the scientific data and discussed their experience in the treatment of hepatitis C related psychiatric problems. The results were first presented at the EASL conference in Berlin in 2011. Since the conference, the recommendations were refined and updated further to include the new antiviral treatments, and will now be published as a “European Expert Consensus Statement“ in the Journal of Hepatology.
09 October 2012 | European Liver Patients Association
-
Taking the antidepressant escitalopram (Lexapro) prior to starting hepatitis C treatment with pegylated interferon reduced the likelihood of depression as well as its severity if it did occur, according to a study described in the July 17, 2012, Annals of Internal Medicine.
24 August 2012 | HIVandHepatitis.com
-
Discussion of stigma and how it affects people with HIV by HIV+ psychotherapist David Fawcett.
16 August 2012 | The Body
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
NAM is the official provider of online scientific news for IAS 2013 18 June 2013The 7th
International AIDS Society Conference on HIV Pathogenesis, Treatment and
Prevention...
Impact of switching to generic drugs in the UK – survey results 11 June 2013A recent NAM survey shows that people living with HIV...
HIV cure research – free webinar 28 May 2013As part of its European HIV prevention work, NAM is
collaborating...